A5103284622- Alzheimer's disease research and treatments
- Intracerebral and Subarachnoid Hemorrhage Research
- Cerebrovascular and genetic disorders
- Systemic Sclerosis and Related Diseases
- Infant Health and Development
- Acupuncture Treatment Research Studies
- Advanced Glycation End Products research
- S100 Proteins and Annexins
- Psychosomatic Disorders and Their Treatments
- Long-Term Effects of COVID-19
- Multiple Sclerosis Research Studies
- Amyloidosis: Diagnosis, Treatment, Outcomes
Sahlgrenska University Hospital
2023-2025
University of Gothenburg
2025
Abstract Brain amyloid‐β (Aβ) deposits are key pathological hallmarks of both cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD). Microvascular in CAA mainly consist the Aβ 40 peptide, whereas 42 is predominant variant parenchymal plaques AD. The relevance pathogenesis diagnostic accuracy various other isoforms remain understudied. We aimed to investigate biomarker potential cerebrospinal fluid (CSF) differentiate from AD pathology. included 25 patients with probable CAA, 50...
Abstract Background Amyloid‐β (Aβ) deposits are the main pathological hallmark of cerebral amyloid angiopathy (CAA) and Alzheimer’s disease (AD). Vascular in CAA mainly consist Aβ 40 , whereas 42 is predominant peptide parenchymal plaques AD. The diagnostic accuracy other species remains understudied. We aimed to investigate biomarker potential various peptides for differentiation sporadic (sCAA) hereditary Dutch‐type (D‐CAA) from AD controls. Method Cerebrospinal fluid (CSF) 38 43 levels...